Bayer Notches Dual EYLEA 8mg Wins With China nAMD Approval and EU 6-Month Interval Extension
High-dose aflibercept secured a regulatory victory in China as 6-month dosing nears European approval Good news apparently comes in twos…
The Next-Gen Arsenal of Genomic Tools for IRDs and Other Eye Diseases Lighting Up ARVO 2025
Innovative genomic techniques on display at ARVO 2025 could slam the door shut on some of the biggest challenges in…
popular posts
